ACTUALIZACIÓN MÉDICO-CONTINUADA EN INMUNODEFICIENCIA SEVERA COMBINADA || Public Health Genomics Knowledge Base (v1.0)

Public Health Genomics Knowledge Base (v1.0)

Search Result Summary

CDC Resources

• CDC Web Information (0)
• CDC-Authored Genomics Publications (0)

Discoveries and Insights

• Hot Topics (1)
• Genomics & Health Impact Scan (1)
AMD Weekly Clips (0)
• Relevant Resources (2)

Epidemiology

• Human Genome Epidemiology (8)
• AMD Clips (0)
• Relevant Resources (1)

Translational Research

• Genomics & Health Impact Scan (1)
• AMD Weekly Clips (0)

Evidence Synthesis

• Guidelines (0)
• Evidence Classification (0)
• Genomics & Health Impact Scan (0)
• Relevant Resources (1)

Practice and Implementation

• Implementation (0)
• Genomics & Health Impact Scan (0)
• Relevant Resources (5)

• Page last updated:Dec 29, 2015

What's New

Last Updated: Oct 22, 2015

• Newborn screening for severe combined immune deficiency (technical and political aspects).
  Kobrynski Lisa et al. Current opinion in allergy and clinical immunology 2015 Oct (From Genomics & Health Impact Scan Database)
• Coiled-coil domain containing 68 (CCDC68) demonstrates a tumor-suppressive role in pancreatic ductal adenocarcinoma.
  Radulovich N, et al. Oncogene 2015 8 (32) 4238-47 (From HuGE Literature Finder)
• Clinical Utility of Patient-Derived Xenografts to Determine Biomarkers of Prognosis and Map Resistance Pathways in EGFR-Mutant Lung Adenocarcinoma.
  Stewart Erin L et al. J. Clin. Oncol. 2015 Jun 29. (From Discoveries and Insights Database)
• Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans.
  (From Genomics & Health Impact Scan Database)
• Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition.
  Irving Julie, et al. Blood 2014 11 (23) 3420-30 (From HuGE Literature Finder)
• CEACAM1 promotes melanoma cell growth through Sox-2.
  Ortenberg Rona, et al. Neoplasia (New York, N.Y.) 2014 5 (5) 451-60 (From HuGE Literature Finder)
• Genomic and molecular characterization of esophageal squamous cell carcinoma.
  Lin De-Chen, et al. Nature genetics 2014 5 (5) 467-73 (From HuGE Literature Finder)
• Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition.
  Kool Marcel, et al. Cancer cell 2014 3 (3) 393-405 (From HuGE Literature Finder)
• The FGFR4-G388R single-nucleotide polymorphism alters pancreatic neuroendocrine tumor progression and response to mTOR inhibition therapy.
  Serra Stefano, et al. Cancer research 2012 11 (22) 5683-91 (From HuGE Literature Finder)
• Customised molecular diagnosis of primary immune deficiency disorders in New Zealand: an efficient strategy for a small developed country.
  Ameratunga Rohan, et al. The New Zealand medical journal 2009 10 (1304) 46-53 (From HuGE Literature Finder)
• Mutation in TET2 in myeloid cancers.
  Delhommeau François, et al. The New England journal of medicine 2009 5 (22) 2289-301 (From HuGE Literature Finder)